Ivermectin and Gynecologic Cancer: What are the data?

•Ivermectin is currently approved by the US Food and Drug Administration (FDA) in 1996 as an oral medication for intestinal strongyloidiasis and onchocerciasis.•The data on ivermectin as a gynecologic cancer-fighting compound is lacking.•Clinical studies on ivermectin use in cancer are limited to ef...

Full description

Bibliographic Details

Published in:	Gynecologic oncology reports Vol. 60; p. 101803
Main Authors:	Mujumdar, Vaidehi, Huang, Marilyn, Smith, Lindsey Chippendale, Musa, Fernanda
Format:	Journal Article
Language:	English
Published:	Elsevier Inc 01.08.2025 Elsevier
Subjects:	Anti-helminthic COVID-19 Gynecologic cancers Ivermectin Wonder drug COVID-19 Gynecologic cancers Wonder drug Anti-helminthic Ivermectin
ISSN:	2352-5789, 2352-5789
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!